Top Markets
#1 TENDIES TENDIES +53.31%
#2 Threshold Network Threshold Network +43.82%
#3 Mubarak Mubarak +31.56%
#4 Akedo Akedo +22.46%
#5 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#6 OSK OSK +16.18%
#7 MultiversX MultiversX +13.97%
#8 Cash Cat Cash Cat +13.56%
#9 Ape and Pepe Ape and Pepe +12.62%
#10 Kite Kite +11.90%
Coin of the day
TENDIES TENDIES
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rang in aandelen #17181
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Aandeelprijs
$1.38
Marktkapitalisatie
$254.97M
Verandering (1 dag)
3.47%
Verandering (1 jaar)
-20.91%
Land
US
Handel Neumora Therapeutics, Inc. Common Stock (NMRA)

Categorie

Healthcare
Koersgeschiedenis voor Neumora Therapeutics, Inc. Common Stock (NMRA)
Hoogste slotkoers: $1.36 op 2026-09-01

Laagste slotkoers: $12.50 op 2023-09-01
Koersgeschiedenis van Neumora Therapeutics, Inc. Common Stock van 2023 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 4.73%
2025 -81.20%
2024 -26.84%
2023 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.56 37.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.97%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $146.95 507.48%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH